63 results
Pulmonary Hypertension Groups - WHO Classification
Group I - Vascular remodeling of pulmonary arteries
 • Idiopathic, HIV,
Groups - WHO Classification ... PH Functional Classification ... Symptoms of right ... ventricular failure might ... #Groups #WHO #Classification
Truncus Arteriosus
 • Basic Information
 • Embryology
 • Associated anomalies
 • Pathophysiology/Presentation
 • Pre-operative management
 •
anomalies • Pathophysiology ... management • Classification ... Cardiomegaly, increased pulmonary ... vasculature, right
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... (Anorexia) • Night ... Tuberculosis Treatment ... Initiating Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... (Anorexia) • Night ... Tuberculosis Treatment ... Initiating Treatment
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess Pathophysiology ... Lung Abscess - Clinical ... degrees • Chills, night ... CXR upright or lat ... Lung #Abscess #pulmonary
Shock Classification Types - Pathophysiology Comparison

Obstructive Shock:
 • Obstructive shock is characterized by a blockage in
Shock Classification ... Types - Pathophysiology ... Pulmonary embolism ... #Shock #Types #Pathophysiology ... criticalcare #diagnosis #classification
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Vaughan Williams Classification ... 0 to decrease rate ... node and AV node activity ... #Pharmacology #Classification ... #Classes #pathophysiology
The interferon (IFN) signature: what’s the point? How to use it in clinical practice?

Characterizing activity of
How to use it in clinical ... Characterizing activity ... pathway in the clinic ... understanding of pathophysiology ... To propose new classifications
Lung Abscess
Microbiology:
 • Polymicrobial 
 • Anaerobes (most common) 
Clinical: 
 • Indolent symptoms that evolve
most common) Clinical ... production • Night ... , hemoptysis Treatment ... Abscess #Diagnosis #Pulmonary ... #Clinical #CXR
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... CKD, CHF, high rate ... , and CXR with pulmonary ... : No • Treatment